SEC Form 4 · accession 0001209191-19-012069
STERIS plc · STE
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Cynthia L Feldmann
Director
Period of report
Feb 20, 2019
Accepted (ET)
Feb 21, 2019 · 4:41 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001624899
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Ordinary Shares, 10 pence par value | Feb 20, 2019 | M | 2,037 | $51.53 | A | 10,700 | D | |
| Ordinary Shares, 10 pence par valueF1 | Feb 20, 2019 | S | 2,037 | $122.51 | D | 8,663 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Director Stock Option (right to buy)F2 | $51.53 | Feb 20, 2019 | M | 2,037 | D | — | Aug 6, 2024 | Ordinary Shares | 2,037 | 0 | D |
Explanation of responses
- F1Price reflects a weighted average sale price for multiple transactions ranging from $122.49 to $122.53 per share, inclusive. The Reporting Person undertakes to provide, upon request by the SEC Staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price
- F2This option to purchase 2,037 STERIS plc ordinary shares, which is fully vested, was received in conjunction with the "Combination" of STERIS Corporation and Synergy Health, Ltd. in exchange for an option to purchase 2,037 STERIS Corporation common shares for $51.53 per share, subject to the same terms and conditions as the original STERIS Corporation stock option.